22942319|t|Metabolism and pharmacokinetics of JM6 in mice: JM6 is not a prodrug for Ro-61-8048.
22942319|a|Understanding whether regulation of tryptophan metabolites can ameliorate neurodegeneration is of high interest to investigators. A recent publication describes 3,4-dimethoxy-N-(4-(3-nitrophenyl)-5-(piperidin-1-ylmethyl)thiazol-2-yl)benzenesulfonamide (JM6) as a novel prodrug for the kynurenine 3-monooxygenase (KMO) inhibitor 3,4-dimethoxy-N-(4-(3-nitrophenyl)thiazol-2-yl)benzenesulfonamide (Ro-61-8048) that elicits therapeutic effects in mouse models of Huntington's and Alzheimer's diseases (Cell 145:863-874, 2011). Our evaluation of the metabolism and pharmacokinetics of JM6 and Ro-61-8048 indicate instead that Ro-61-8048 concentrations in mouse plasma after JM6 administration originate from a Ro-61-8048 impurity (<0.1%) in JM6. After a 0.05 mg/kg Ro-61-8048 oral dose alone or coadministered with 10 mg/kg JM6 to mice, the Ro-61-8048 areas under the concentration-time curves (AUCs) from 0 to infinity were similar (4300 and 4900 nM x h, respectively), indicating no detectable contributions of JM6 metabolism to the Ro-61-8048 AUCs. JM6 was stable in incubations under acidic conditions and Ro-61-8048 was not a product of JM6 metabolism in vitro (plasma, blood, or hepatic models). Species differences in the quantitative rate of oxidative metabolism indicate that major circulating JM6 metabolite(s) in mice are unlikely to be major in humans: JM6 is rapidly metabolized via the piperidyl moiety in mouse (forming an iminium ion reactive intermediate) but is slowly metabolized in human (in vitro), primarily via O-dealkylation at the phenyl ring. Our data indicate that JM6 is not a prodrug for Ro-61-8048 and is not a potent KMO inhibitor.
22942319	35	38	JM6	Chemical	MESH:C024235
22942319	42	46	mice	Species	10090
22942319	48	51	JM6	Chemical	MESH:C024235
22942319	73	83	Ro-61-8048	Chemical	MESH:C110196
22942319	121	131	tryptophan	Chemical	MESH:D014364
22942319	159	176	neurodegeneration	Disease	MESH:D019636
22942319	246	336	3,4-dimethoxy-N-(4-(3-nitrophenyl)-5-(piperidin-1-ylmethyl)thiazol-2-yl)benzenesulfonamide	Chemical	-
22942319	338	341	JM6	Chemical	MESH:C024235
22942319	370	396	kynurenine 3-monooxygenase	Gene	98256
22942319	398	401	KMO	Gene	98256
22942319	413	478	3,4-dimethoxy-N-(4-(3-nitrophenyl)thiazol-2-yl)benzenesulfonamide	Chemical	-
22942319	480	490	Ro-61-8048	Chemical	MESH:C110196
22942319	528	533	mouse	Species	10090
22942319	544	556	Huntington's	Disease	MESH:D006816
22942319	561	581	Alzheimer's diseases	Disease	MESH:D000544
22942319	665	668	JM6	Chemical	MESH:C024235
22942319	673	683	Ro-61-8048	Chemical	MESH:C110196
22942319	706	716	Ro-61-8048	Chemical	MESH:C110196
22942319	735	740	mouse	Species	10090
22942319	754	757	JM6	Chemical	MESH:C024235
22942319	790	800	Ro-61-8048	Chemical	MESH:C110196
22942319	821	824	JM6	Chemical	MESH:C024235
22942319	845	855	Ro-61-8048	Chemical	MESH:C110196
22942319	904	907	JM6	Chemical	MESH:C024235
22942319	911	915	mice	Species	10090
22942319	921	931	Ro-61-8048	Chemical	MESH:C110196
22942319	1093	1096	JM6	Chemical	MESH:C024235
22942319	1115	1125	Ro-61-8048	Chemical	MESH:C110196
22942319	1132	1135	JM6	Chemical	MESH:C024235
22942319	1190	1200	Ro-61-8048	Chemical	MESH:C110196
22942319	1222	1225	JM6	Chemical	MESH:C024235
22942319	1383	1386	JM6	Chemical	MESH:C024235
22942319	1404	1408	mice	Species	10090
22942319	1437	1443	humans	Species	9606
22942319	1445	1448	JM6	Chemical	MESH:C024235
22942319	1500	1505	mouse	Species	10090
22942319	1518	1529	iminium ion	Chemical	-
22942319	1582	1587	human	Species	9606
22942319	1672	1675	JM6	Chemical	MESH:C024235
22942319	1697	1707	Ro-61-8048	Chemical	MESH:C110196
22942319	1728	1731	KMO	Gene	98256
22942319	Negative_Correlation	MESH:C110196	MESH:D000544
22942319	Negative_Correlation	MESH:C110196	MESH:D006816
22942319	Comparison	MESH:C024235	MESH:C110196
22942319	Negative_Correlation	MESH:C024235	98256
22942319	Association	MESH:D014364	MESH:D019636
22942319	Negative_Correlation	MESH:C110196	98256

